Autophagy and heart failure: a possible role for homocysteine

Area of Science:

• Cardiovascular Biology
• Cellular Biology
• Molecular Medicine

Background:

• Autophagy is a fundamental cellular process involving the degradation of cellular components.
• Cardiomyocytes, long-lived cells in the heart, are particularly relevant to autophagy in the context of heart disease.
• The precise role of autophagy in cardiovascular pathology remains incompletely understood, with evidence suggesting context-dependent beneficial or detrimental effects.

Purpose of the Study:

• To elucidate the intricate pathways and mediators involved in autophagy.
• To investigate the complex relationship between autophagy and heart disease, particularly concerning the role of homocysteine (Hcy).
• To explore the potential therapeutic implications of targeting autophagy in cardiovascular conditions.

Main Methods:

• Review and synthesis of existing literature on autophagy pathways and mediators (e.g., Atg, Beclin-1, LAMP-2, BH3, Bcl2, PI3K Kinase).
• Analysis of studies linking homocysteine levels to autophagy induction and repression.
• Examination of proposed mechanisms connecting Hcy to cellular processes like nitrous oxide, calcium, and reactive oxygen species production.

Main Results:

• Autophagy's role in heart disease is multifaceted, potentially preserving cells during ischemia but harming them during reperfusion.
• Elevated homocysteine (Hcy) is an independent risk factor for chronic heart failure.
• Hcy is linked to autophagy modulation through effects on intracellular nitrous oxide, calcium, and reactive oxygen species.

Conclusions:

• The precise mechanisms governing autophagy in heart disease, especially Hcy-mediated effects, require further investigation.
• Autophagy's dual role highlights the need for context-specific therapeutic strategies.
• Targeting autophagy pathways presents promising therapeutic avenues for managing heart failure and related cardiovascular conditions.